UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Acquires 9,395 Shares of U.S. Physical Therapy, Inc. (NYSE:USPH)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 35.6% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 35,761 shares of the company's stock after buying an additional 9,395 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned about 0.24% of U.S. Physical Therapy worth $3,172,000 at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in USPH. CBIZ Investment Advisory Services LLC boosted its holdings in shares of U.S. Physical Therapy by 59.8% during the fourth quarter. CBIZ Investment Advisory Services LLC now owns 326 shares of the company's stock worth $29,000 after acquiring an additional 122 shares during the period. Point72 Asia Singapore Pte. Ltd. acquired a new stake in U.S. Physical Therapy during the 4th quarter worth approximately $39,000. Venturi Wealth Management LLC lifted its holdings in U.S. Physical Therapy by 3,200.0% during the 4th quarter. Venturi Wealth Management LLC now owns 726 shares of the company's stock worth $64,000 after purchasing an additional 704 shares during the last quarter. Lazard Asset Management LLC acquired a new position in U.S. Physical Therapy in the 4th quarter valued at $84,000. Finally, Aquatic Capital Management LLC grew its holdings in U.S. Physical Therapy by 18.0% in the 4th quarter. Aquatic Capital Management LLC now owns 1,298 shares of the company's stock valued at $115,000 after buying an additional 198 shares in the last quarter.

U.S. Physical Therapy Trading Up 1.7%

Shares of NYSE:USPH traded up $1.32 during mid-day trading on Monday, reaching $78.57. 180,611 shares of the company's stock were exchanged, compared to its average volume of 113,815. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.78 and a current ratio of 1.78. U.S. Physical Therapy, Inc. has a twelve month low of $62.77 and a twelve month high of $101.20. The firm has a market capitalization of $1.19 billion, a price-to-earnings ratio of 83.59, a PEG ratio of 3.54 and a beta of 1.45. The business's fifty day moving average price is $72.29 and its 200-day moving average price is $81.99.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last announced its earnings results on Wednesday, May 7th. The company reported $0.48 EPS for the quarter, topping the consensus estimate of $0.46 by $0.02. The firm had revenue of $183.79 million for the quarter, compared to the consensus estimate of $176.78 million. U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. The business's quarterly revenue was up 18.0% compared to the same quarter last year. During the same period in the previous year, the business earned $0.51 EPS. On average, research analysts predict that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current fiscal year.

U.S. Physical Therapy Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, June 13th. Investors of record on Friday, May 23rd will be issued a $0.45 dividend. The ex-dividend date is Friday, May 23rd. This represents a $1.80 annualized dividend and a yield of 2.29%. U.S. Physical Therapy's payout ratio is 82.57%.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on the stock. Wall Street Zen raised shares of U.S. Physical Therapy from a "sell" rating to a "hold" rating in a research report on Thursday, May 8th. William Blair reissued a "market perform" rating on shares of U.S. Physical Therapy in a report on Thursday, February 27th. Barrington Research cut their price target on shares of U.S. Physical Therapy from $108.00 to $98.00 and set an "outperform" rating for the company in a report on Friday, February 28th. JMP Securities reissued a "market outperform" rating and issued a $113.00 price objective on shares of U.S. Physical Therapy in a research note on Tuesday, April 22nd. Finally, JPMorgan Chase & Co. lowered their price objective on shares of U.S. Physical Therapy from $120.00 to $110.00 and set an "overweight" rating for the company in a research report on Wednesday, March 19th. Two research analysts have rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $109.00.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.